Literature DB >> 33736617

Group meta-cognitive therapy and depression in women with breast cancer: a randomized controlled trial.

Elham Zahedian1, Masoud Bahreini2, Nezamaddin Ghasemi3, Kamran Mirzaei4.   

Abstract

BACKGROUND: Breast cancer is one of the most common cancers in Iranian women. They will experience a mental health problem like depression before, during or after treatment. This study aimed to determine the effectiveness of group metacognitive therapy on depression, cognitive-emotional regulation, and meta-cognitive beliefs in women with breast cancer.
METHODS: In this randomized controlled clinical trial, a total of 24 depressed patients with breast cancer were randomly allocated to experimental and control groups. The experimental group received meta-cognitive therapy in 8 weekly sessions, but the control group received treatment as usual. Beck Depressive Inventory, cognitive emotion regulation questionnaire, and meta-cognitions questionnaire were completed before, after and one month after the intervention. Data were analyzed using Wilcoxon and Chi-square tests.
RESULTS: The mean score of depression in the experimental group was reduced from 21.6 ± 4.83 in the pre-test to 13.83 ± 8.12 in one-month follow-up (p = 0.16); however, there was no significant difference in the control group. The mean score of cognitive emotion regulation did not show a significant change in the two groups during the study and follow-up period. The mean score of meta-cognitive beliefs reached 68.75 ± 15.74 from 79.51 ± 10.72 in the experimental group during the follow-up period (p = 0.006); however, there was no significant difference in the control group in the score of metacognitive beliefs.
CONCLUSION: These findings support the efficacy of meta-cognitive therapy as a viable psychosocial intervention in depressed patients with breast cancer. Trial registration IRCT201606288473N5. Registered on: 05/09/2016 https://www.irct.ir/trial/8946 .

Entities:  

Keywords:  Breast cancer; Cognitive emotion regulation; Depression; Meta-cognitive therapy; Metacognitive beliefs

Mesh:

Year:  2021        PMID: 33736617      PMCID: PMC7977266          DOI: 10.1186/s12905-021-01258-9

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  22 in total

1.  A short form of the metacognitions questionnaire: properties of the MCQ-30.

Authors:  Adrian Wells; Sam Cartwright-Hatton
Journal:  Behav Res Ther       Date:  2004-04

2.  Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States.

Authors:  Angela B Mariotto; Ruth Etzioni; Marc Hurlbert; Lynne Penberthy; Musa Mayer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-05-18       Impact factor: 4.254

3.  Psychometric properties of a Persian-language version of the Beck Depression Inventory--Second edition: BDI-II-PERSIAN.

Authors:  Habibollah Ghassemzadeh; Ramin Mojtabai; Narges Karamghadiri; Narges Ebrahimkhani
Journal:  Depress Anxiety       Date:  2005       Impact factor: 6.505

4.  Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life.

Authors:  Omur Karakoyun-Celik; Ilknur Gorken; Sema Sahin; Esmahan Orcin; Hilmi Alanyali; Munir Kinay
Journal:  Med Oncol       Date:  2009-02-19       Impact factor: 3.064

Review 5.  Survival Rates for Breast Cancer in Iranian Patients: a Meta- Analysis.

Authors:  Mitra Rahimzadeh; Mohamad Amin Pourhoseingholi; Behrooz Kavehie
Journal:  Asian Pac J Cancer Prev       Date:  2016

6.  Breast cancer statistics, 2017, racial disparity in mortality by state.

Authors:  Carol E DeSantis; Jiemin Ma; Ann Goding Sauer; Lisa A Newman; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-10-03       Impact factor: 508.702

7.  Comparison of effectiveness of the metacognition treatment and the mindfulness-based stress reduction treatment on global and specific life quality of women with breast cancer.

Authors:  Soheila Rahmani; Siavash Talepasand; ALi Ghanbary-Motlagh
Journal:  Iran J Cancer Prev       Date:  2014

8.  The Efficacy of Metacognitive Therapy: A Systematic Review and Meta-Analysis.

Authors:  Nicoline Normann; Nexhmedin Morina
Journal:  Front Psychol       Date:  2018-11-14

Review 9.  Metacognitive therapy versus cognitive-behavioural therapy in adults with generalised anxiety disorder.

Authors:  Hans M Nordahl; Thomas D Borkovec; Roger Hagen; Leif E O Kennair; Odin Hjemdal; Stian Solem; Bjarne Hansen; Svein Haseth; Adrian Wells
Journal:  BJPsych Open       Date:  2018-09-11

Review 10.  Psychological Consequences of Breast Cancer in Iran: A Meta-Analysis.

Authors:  Nasrin Refaee Saeedi; Hamidreza Aghamohammadian Sharbaf; Mohammad Javad Asghari Ebrahimabad; Hossein Kareshki
Journal:  Iran J Public Health       Date:  2019-05       Impact factor: 1.429

View more
  1 in total

1.  The effectiveness of group problem-solving therapy on women's sexual function and satisfaction after mastectomy surgery.

Authors:  Mahshid Bokaie; Ommolbanin Firouzabadi; Azadeh Joulaee
Journal:  BMC Womens Health       Date:  2022-02-23       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.